Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors
Pancreatology · 2023
DOI: 10.1016/j.pan.2023.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Bálint Zoltán Németh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/C, H-1117, Budapest, Hungary. Hauptthemen laut MEDLINE: Chymases, Chymotrypsin, Protease Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, European Union.
Abstract (Originalsprache)
Chymotrypsin-like protease (CTRL) is one of the four chymotrypsin isoforms expressed in the human exocrine pancreas. Human genetic and experimental evidence indicate that chymotrypsins B1, B2, and C (CTRB1, CTRB2 and CTRC) are important not only for protein digestion but also for protecting the pancreas against pancreatitis by degrading potentially harmful trypsinogen. CTRL has not been reported to play a similar role, possibly due to its low abundance and/or different substrate specificity. To address this problem, we investigated the specificity of the substrate-binding groove of CTRL by evolving the substrate-like canonical loop of the Schistocerca gregaria proteinase inhibitor 2 (SGPI-2), a small-protein reversible chymotrypsin inhibitor to bind CTRL. We found that phage-associated SGPI-2 variants with strong affinity to CTRL were similar to those evolved previously against CTRB1, CTRB2 or bovine chymotrypsin A (bCTRA), indicating comparable substrate specificity. When tested as recombinant proteins, SGPI-2 variants inhibited CTRL with similar or slightly weaker affinity than bCTRA, confirming that CTRL is a typical chymotrypsin. Interestingly, an SGPI-2 variant selected with a Thr29His mutation in its reactive loop was found to inhibit CTRL strongly, but it was digested rapidly by bCTRA. Finally, CTRL was shown to degrade human anionic trypsinogen, however, at a much slower rate than CTRB2, suggesting that CTRL may not have a significant role in the pancreatic defense mechanisms against inappropriate trypsinogen activation and pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/C, H-1117, Budapest, Hungary.
- Department of Analytical Chemistry, MTA-ELTE Lendület Ion Mobility Mass Spectrometry Research Group, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/A, Budapest, H-1117, Budapest, Hungary.
- Department of Surgery, University of California Los Angeles, Los Angeles, CA, 90095, USA.
- Department of Surgery, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA.
- Institute for Translational Medicine, University of Pécs, Medical School, H-7624, Pécs, Hungary.
- Department of Biochemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/C, H-1117, Budapest, Hungary. Electronic address: gabor.pal@ttk.elte.hu.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
- European Union
- Hungarian Scientific Research Fund
- Hungarian Academy of Sciences
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- European Regional Development Fund
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
Zitieren
APA
Németh, B. Z., Nagy, Z. A., Kiss, B., Gellén, G., Schlosser, G., Demcsák, A., Geisz, A., Hegyi, E., Sahin-Tóth, M., & Pál, G. (2023). Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors. Pancreatology. https://doi.org/10.1016/j.pan.2023.08.004
Vancouver
Németh BZ, Nagy ZA, Kiss B, Gellén G, Schlosser G, Demcsák A, et al. Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors. Pancreatology. 2023. doi:10.1016/j.pan.2023.08.004
BibTeX
@article{Nmeth2023,
author = {Németh, Bálint Zoltán and Nagy, Zoltán Attila and Kiss, Bence and Gellén, Gabriella and Schlosser, Gitta and Demcsák, Alexandra and Geisz, Andrea and Hegyi, Eszter and Sahin-Tóth, Miklós and Pál, Gábor},
title = {Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors},
journal = {Pancreatology},
year = {2023},
doi = {10.1016/j.pan.2023.08.004}
}
EUVIMED